Cargando…

DNA methylation at enhancers identifies distinct breast cancer lineages

Breast cancers exhibit genome-wide aberrant DNA methylation patterns. To investigate how these affect the transcriptome and which changes are linked to transformation or progression, we apply genome-wide expression–methylation quantitative trait loci (emQTL) analysis between DNA methylation and gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fleischer, Thomas, Tekpli, Xavier, Mathelier, Anthony, Wang, Shixiong, Nebdal, Daniel, Dhakal, Hari P., Sahlberg, Kristine Kleivi, Schlichting, Ellen, Børresen-Dale, Anne-Lise, Borgen, Elin, Naume, Bjørn, Eskeland, Ragnhild, Frigessi, Arnoldo, Tost, Jörg, Hurtado, Antoni, Kristensen, Vessela N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680222/ https://www.ncbi.nlm.nih.gov/pubmed/29123100 http://dx.doi.org/10.1038/s41467-017-00510-x

Ejemplares similares

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
por: Tekpli, Xavier, et al.
Publicado: (2019)

Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer
por: Tinholt, Mari, et al.
Publicado: (2020)

Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer
por: Aure, Miriam Ragle, et al.
Publicado: (2021)

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
por: Lindholm, Evita Maria, et al.
Publicado: (2019)

Overrepresentation of transcription factor families in the genesets underlying breast cancer subtypes
por: Joshi, Himanshu, et al.
Publicado: (2012)

Pioneer transcription factors are associated with the modulation of DNA methylation patterns across cancers
por: Lemma, Roza Berhanu, et al.
Publicado: (2022)

Combining Gene Signatures Improves Prediction of Breast Cancer Survival
por: Zhao, Xi, et al.
Publicado: (2011)

Subtype and cell type specific expression of lncRNAs provide insight into breast cancer
por: Bjørklund, Sunniva Stordal, et al.
Publicado: (2022)

Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer
por: Solvang, Hiroko K, et al.
Publicado: (2011)

Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
por: Fleischer, Thomas, et al.
Publicado: (2014)

Identifying In-Trans Process Associated Genes in Breast Cancer by Integrated Analysis of Copy Number and Expression Data
por: Aure, Miriam Ragle, et al.
Publicado: (2013)

Transcriptomic pan‐cancer analysis using rank‐based Bayesian inference
por: Vitelli, Valeria, et al.
Publicado: (2023)

DNA methylation and gene expression patterns in breast cancer progression from in situ carcinoma to invasive carcinoma
por: Fleischer, Thomas, et al.
Publicado: (2013)

Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018
por: Skjerven, Helle Kristine, et al.
Publicado: (2022)

Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients
por: Westbury, Charlotte B, et al.
Publicado: (2011)

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
por: Tinholt, Mari, et al.
Publicado: (2015)

miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy
por: Normann, Lisa Svartdal, et al.
Publicado: (2022)

Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors
por: Aure, Miriam Ragle, et al.
Publicado: (2013)

Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
por: Tinholt, Mari, et al.
Publicado: (2014)

Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy
por: Halvorsen, Ann Rita, et al.
Publicado: (2014)

Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up
por: Ohnstad, Hege O., et al.
Publicado: (2017)

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
por: Silwal-Pandit, Laxmi, et al.
Publicado: (2015)

A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2016)

Correction to: A systematic comparison of copy number alterations in four types of female cancer
por: Kaveh, Fatemeh, et al.
Publicado: (2018)

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro
por: Normann, Lisa Svartdal, et al.
Publicado: (2021)

Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010)

Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer
por: Aure, Miriam Ragle, et al.
Publicado: (2015)

Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
por: Nordgard, Silje H, et al.
Publicado: (2007)

DNA copy number motifs are strong and independent predictors of survival in breast cancer
por: Pladsen, Arne V., et al.
Publicado: (2020)

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
por: Höglander, Elen Kristine, et al.
Publicado: (2018)

miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
por: Enerly, Espen, et al.
Publicado: (2011)

Correction: miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
por: Enerly, Espen, et al.
Publicado: (2013)

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
por: Klajic, Jovana, et al.
Publicado: (2013)

Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics
por: Jabeen, Shakila, et al.
Publicado: (2018)

miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer
por: Ben-Elazar, Shay, et al.
Publicado: (2021)

The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients
por: Mikalsen, Lars Tore Gyland, et al.
Publicado: (2013)

Next-Generation Sequencing of Disseminated Tumor Cells
por: Møller, Elen K., et al.
Publicado: (2013)

Genome‐wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis
por: Bjaanæs, Maria Moksnes, et al.
Publicado: (2015)

LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer
por: Sas‐Chen, Aldema, et al.
Publicado: (2016)

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
por: Normann, Lisa Svartdal, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r2oqs0vjc9r948vd83ausarge5